Forum Financial Management LP Raises Stock Position in HCA Healthcare, Inc. $HCA

Forum Financial Management LP increased its stake in HCA Healthcare, Inc. (NYSE:HCA) by 6.3% during the 2nd quarter, HoldingsChannel reports. The firm owned 1,098 shares of the company’s stock after buying an additional 65 shares during the period. Forum Financial Management LP’s holdings in HCA Healthcare were worth $421,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. ORG Partners LLC boosted its holdings in HCA Healthcare by 27.9% in the second quarter. ORG Partners LLC now owns 142 shares of the company’s stock worth $55,000 after purchasing an additional 31 shares during the last quarter. Avantax Advisory Services Inc. boosted its stake in shares of HCA Healthcare by 0.4% during the 1st quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company’s stock worth $2,791,000 after acquiring an additional 32 shares during the last quarter. Glenview Trust co boosted its stake in shares of HCA Healthcare by 2.3% during the 1st quarter. Glenview Trust co now owns 1,451 shares of the company’s stock worth $501,000 after acquiring an additional 32 shares during the last quarter. Horizon Investments LLC boosted its stake in shares of HCA Healthcare by 1.1% during the 1st quarter. Horizon Investments LLC now owns 3,175 shares of the company’s stock worth $1,097,000 after acquiring an additional 33 shares during the last quarter. Finally, Sivia Capital Partners LLC boosted its stake in shares of HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after acquiring an additional 33 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $446.58 on Friday. The company has a market cap of $104.50 billion, a P/E ratio of 17.26, a P/E/G ratio of 1.41 and a beta of 1.40. The firm’s fifty day moving average is $414.84 and its two-hundred day moving average is $382.03. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $461.56.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. During the same period in the previous year, the firm posted $4.90 EPS. HCA Healthcare’s revenue for the quarter was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be issued a $0.72 dividend. The ex-dividend date is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is 12.11%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Morgan Stanley dropped their price target on shares of HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating on the stock in a research note on Monday, July 28th. Wells Fargo & Company raised their price objective on shares of HCA Healthcare from $375.00 to $412.00 and gave the company an “equal weight” rating in a research report on Tuesday, October 7th. Wall Street Zen upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Robert W. Baird raised their price objective on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research report on Thursday, August 14th. Finally, KeyCorp raised their price objective on shares of HCA Healthcare from $370.00 to $465.00 and gave the company an “overweight” rating in a research report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $437.19.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.